Guideline: Vulvovaginal Candidosis (AWMF 015/072), S2k (Excluding Chronic Mucocutaneous Candidosis)

Mendling, Werner

doi:10.1111/myc.12292

Cited by 120Antifungal resistance and susceptibilityReproductive tract infections researchYeasts and Rust Fungi Studies

Guideline: Vulvovaginal Candidosis (AWMF 015/072), S2k (Excluding Chronic Mucocutaneous Candidosis)

Open access

Mendling, Werner·2015·Mycoses

DOI 10.1111/myc.12292

Open this paper in CoChat — free account Open PDF

Abstract

The oestrogenised vagina is colonised by Candida species in at least 20% of women; in late pregnancy and in immunosuppressed patients, this increases to at least 30%. In most cases, Candida albicans is involved. Host factors, particularly local defence mechanisms, gene polymorphisms, allergies, serum glucose levels, antibiotics, psycho-social stress and oestrogens influence the risk of candidal vulvovaginitis. Non-albicans species, particularly Candida glabrata, and in rare cases also Saccharomyces cerevisiae, cause less than 10% of all cases of vulvovaginitis with some regional variation; these are generally associated with milder signs and symptoms than normally seen with a C. albicans-associated vaginitis. Typical symptoms include premenstrual itching, burning, redness and odourless discharge. Although itching and redness of the introitus and vagina are typical symptoms, only 35-40% of women reporting genital itching in fact suffer from vulvovaginal candidosis. Medical history, clinical examination and microscopic examination of vaginal content using 400× optical magnification, or preferably phase contrast microscopy, are essential for diagnosis. In clinically and microscopically unclear cases and in chronically recurring cases, a fungal culture for pathogen determination should be performed. In the event of non-C. albicans species, the minimum inhibitory concentration (MIC) should also be determined. Chronic mucocutaneous candidosis, a rarer disorder which can occur in both sexes, has other causes and requires different diagnostic and treatment measures. Treatment with all antimycotic agents on the market (polyenes such as nystatin; imidazoles such as clotrimazole; and many others including ciclopirox olamine) is easy to administer in acute cases and is successful in more than 80% of cases. All vaginal preparations of polyenes, imidazoles and ciclopirox olamine and oral triazoles (fluconazole, itraconazole) are equally effective (Table ); however, oral triazoles should not be administered during pregnancy according to the manufacturers. C. glabrata is not sufficiently sensitive to the usual dosages of antimycotic agents approved for gynaecological use. In other countries, vaginal suppositories of boric acid (600 mg, 1-2 times daily for 14 days) or flucytosine are recommended. Boric acid treatment is not allowed in Germany and flucytosine is not available. Eight hundred-milligram oral fluconazole per day for 2-3 weeks is therefore recommended in Germany. Due to the clinical persistence of C. glabrata despite treatment with high-dose fluconazole, oral posaconazole and, more recently, echinocandins such as micafungin are under discussion; echinocandins are very expensive, are not approved for this indication and are not supported by clinical evidence of their efficacy. In cases of vulvovaginal candidosis, resistance to C. albicans does not play a significant role in the use of polyenes or azoles. Candida krusei is resistant to the triazoles, fluconazole and itraconazole. For this reason, local imidazole, ciclopirox olamine or nystatin should be used. There are no studies to support this recommendation, however. Side effects, toxicity, embryotoxicity and allergies are not clinically significant. Vaginal treatment with clotrimazole in the first trimester of a pregnancy reduces the rate of premature births. Although it is not necessary to treat a vaginal colonisation of Candida in healthy women, vaginal administration of antimycotics is often recommended in the third trimester of pregnancy in Germany to reduce the rate of oral thrush and napkin dermatitis in healthy full-term newborns. Chronic recurrent vulvovaginal candidosis continues to be treated in intervals using suppressive therapy as long as immunological treatments are not available. The relapse rate associated with weekly or monthly oral fluconazole treatment over 6 months is approximately 50% after the conclusion of suppressive therapy according to current studies. Good results have been achieved with a fluconazole regimen using an initial 200 mg fluconazole per day on 3 days in the first week and a dosage-reduced maintenance therapy with 200 mg once a month for 1 year when the patient is free of symptoms and fungal infection (Table ). Future studies should include Candida autovaccination, antibodies to Candida virulence factors and other immunological experiments. Probiotics with appropriate lactobacillus strains should also be examined in future studies on the basis of encouraging initial results. Because of the high rate of false indications, OTC treatment (self-treatment by the patient) should be discouraged.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/myc.12292

Cites

162 of 162 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

In approximately 50% of patients treated with fluconazole, VVC recurs after 6 months.
“Moreover, in approximately 50% of patients treated with fluconazole, VVC recurs after 6 months [37].”
From Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods (2023) · cites this paper as [37]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Immunity to fungal infections
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793 · see citing works
Vulvovaginal candidosis
Sobel, J. D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60917-9 · Cited by 1,270 · see citing works
Candida glabrata : Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicans
Fidel, P. L., Vazquez, J. A., & Sobel, J. D. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.80 · Cited by 953 · see citing works
Potential Role of Phospholipases in Virulence and Fungal Pathogenesis
Ghannoum, M. A. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.122-143.2000 · Cited by 814 · see citing works
Human dectin-1 deficiency and mucocutaneous fungal infections
Ferwerda, B., Ferwerda, G., Plantinga, T. S., Willment, J. A., van Spriel, A. B., Venselaar, H., Elbers, C. C., Johnson, M. D., Cambi, A., Huysamen, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901053 · Cited by 752 · see citing works
Maintenance Fluconazole Therapy for Recurrent Vulvovaginal Candidiasis
Sobel, J. D., Wiesenfeld, H. C., Martens, M., Danna, P., Hooton, T. M., Rompalo, A., Sperling, M., Livengood, C., Horowitz, B., Von Thron, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033114 · Cited by 487 · see citing works
Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases
Richter, S. S., Galask, R. P., Messer, S. A., Hollis, R. J., Diekema, D. J., & Pfaller, M. A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.5.2155-2162.2005 · Cited by 435 · see citing works
Candida albicans proteinases and host/pathogen interactions
Naglik, J., Albrecht, A., Bader, O., & Hube, B. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00439.x · Cited by 399 · see citing works
Evaluation of Vaginal Complaints
Anderson, M. (2004) · JAMA · doi:10.1001/jama.291.11.1368 · Cited by 375 · see citing works
Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery
Kiss, H., Petričević, L., & Husslein, P. W. (2004) · BMJ · doi:10.1136/bmj.38169.519653.eb · Cited by 329 · see citing works
Ingestion of Yogurt Containing Lactobacillus acidophilus as Prophylaxis for Candidal Vaginitis
Hilton, E., Isenberg, H. D., Alperstein, P., France, K., & Borenstein, M. T. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-5-353 · Cited by 288 · see citing works
Prevalence of Recurrent Vulvovaginal Candidiasis in 5 European Countries and the United States: Results From an Internet Panel Survey
Foxman, B., Muraglia, R., Dietz, J.-P., Sobel, J. D., & Wagner, J. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e318273e8cf · Cited by 261 · see citing works
Probiotics for prevention of recurrent vulvovaginal candidiasis: a review
Falagas, M. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl246 · Cited by 248 · see citing works
Prevalence and risk factors for vaginal Candidacolonization in women with type 1 and type 2 diabetes
de Leon, E. M., Jacober, S. J., Sobel, J. D., & Foxman, B. (2002) · BMC Infectious Diseases · doi:10.1186/1471-2334-2-1 · Cited by 246 · see citing works
A comparison of secretory proteinases from different strains ofCandida albicans
Rüchel, R., Tegeler, R., & Trost, M. (1982) · Medical Mycology · doi:10.1080/00362178285380341 · Cited by 240 · see citing works
Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm
Eckert, L. O. (1998) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(98)00264-6 · Cited by 232 · see citing works
Adherence of Candida albicans to Human Vaginal and Buccal Epithelial Cells
Sobel, J. D., Myers, P. G., Kaye, D., & Levison, M. E. (1981) · The Journal of Infectious Diseases · doi:10.1093/infdis/143.1.76 · Cited by 231 · see citing works
Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis
Ferris, D. G. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01759-8 · Cited by 196 · see citing works
An epidemiological survey of vulvovaginal candidiasis in Italy
Corsello, S., Spinillo, A., Osnengo, G., Penna, C., Guaschino, S., Beltrame, A., Blasi, N., & Festa, A. (2003) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(03)00096-4 · Cited by 181 · see citing works
Evidence for a Correlation Between Proteinase Secretion and Vulvovaginal Candidosis
Cassone, A., Bernardis, F. D., Mondello, F., Ceddia, T., & Agatensi, L. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/156.5.777 · Cited by 171 · see citing works
Repeated Vulvovaginal Fungal Infections Cause Persistent Pain in a Mouse Model of Vulvodynia
Farmer, M. A., Taylor, A. M. W., Bailey, A. L., Tuttle, A. H., MacIntyre, L., Milagrosa, Z. E., Crissman, H. P., Bennett, G. J., Ribeiro‐da‐Silva, A., Binik, Y. M., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002613 · Cited by 149 · see citing works
Chronic fungal vaginitis: The value of cultures
Nyirjesy, P., Seeney, S. M., GRODY, M. H. T., Jordan, C. A., & BUCKLEY, H. R. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90347-x · Cited by 146 · see citing works
Species-specific Prevalence of Vaginal Candidiasis Among Patients with Diabetes Mellitus and its Relation to their Glycaemic Status
Goswami, R., Dadhwal, V., Tejaswi, S., Datta, K., Paul, A., Haricharan, R. N., Banerjee, U., & Kochupillai, N. (2000) · Journal of Infection · doi:10.1053/jinf.2000.0723 · Cited by 146 · see citing works
Ciclopirox Olamine Treatment Affects the Expression Pattern ofCandida albicansGenes Encoding Virulence Factors, Iron Metabolism Proteins, and Drug Resistance Factors
Niewerth, M., Kunze, D., Seibold, M., Schaller, M., Körting, H. C., & Hube, B. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.1805-1817.2003 · Cited by 145 · see citing works
C-type lectin Langerin is a β-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi
de Jong, M. A. W. P., Vriend, L. E. M., Theelen, B., Taylor, M. E., Fluitsma, D. M., Boekhout, T., & Geijtenbeek, T. B. H. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2009.12.016 · Cited by 139 · see citing works
Genital Candida Species Detected in Samples from Women in Melbourne, Australia, before and after Treatment with Antibiotics
Pirotta, M. V., & Garland, S. M. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00218-06 · Cited by 136 · see citing works
Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial
Pirotta, M. V., Gunn, J. M., Chondros, P., Grover, S. R., O'Malley, P., Hurley, S., & Garland, S. M. (2004) · BMJ · doi:10.1136/bmj.38210.494977.de · Cited by 136 · see citing works
Vaginal Yeast Colonization in Nonpregnant Women: A Longitudinal Study
Beigi, R. H., Meyn, L. A., Moore, D. M., Krohn, M. A., & Hillier, S. L. (2004) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000140687.51048.73 · Cited by 134 · see citing works
The epidemiology of vulvovaginal candidiasis: risk factors.
Foxman, B. (1990) · American Journal of Public Health · doi:10.2105/ajph.80.3.329 · Cited by 133 · see citing works
Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis
Babula, O., Lazdane, G., Kroica, J., Linhares, I. M., Ledger, W. J., & Witkin, S. S. (2005) · Clinical Infectious Diseases · doi:10.1086/429246 · Cited by 130 · see citing works
Candida and Candidosis
Mackenzie, D. (1988) · Journal of Clinical Pathology · doi:10.1136/jcp.41.11.1247-c · Cited by 127 · see citing works
Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial)
Donders, G., Bellen, G., Byttebier, G., Verguts, L., Hinoul, P., Walckiers, R., Stalpaert, M., Vereecken, A., & Van Eldere, J. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.06.029 · Cited by 127 · see citing works
Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis
van de Wijgert, J. H. H. M., Verwijs, M. C., Turner, A. N., & MORRISON, C. S. (2013) · AIDS · doi:10.1097/qad.0b013e32836290b6 · Cited by 126 · see citing works
Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA
Aballéa, S., Guelfucci, F., Wagner, J., Khemiri, A., Dietz, J.-P., Sobel, J. D., & Toumi, M. (2013) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-11-169 · Cited by 126 · see citing works
Evidence for a Role for Secreted Aspartate Proteinase of Candida albicans in Vulvovaginal Candidiasis
Bernardis, F. D., Agatensi, L., Ross, I. K., Emerson, G. W., Lorenzini, R., Sullivan, P. A., & Cassone, A. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.6.1276 · Cited by 126 · see citing works
Survey of Vaginal-Flora Candida Species Isolates from Women of Different Age Groups by Use of Species-Specific PCR Detection
Vermitsky, J., Self, M. J., Chadwick, S. G., Trama, J. P., Adelson, M. E., Mordechai, E., & Gygax, S. E. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02485-07 · Cited by 123 · see citing works
Use of Oral Fluconazole during Pregnancy and the Risk of Birth Defects
Mølgaard‐Nielsen, D., Pasternak, B., & Hviid, A. P. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301066 · Cited by 121 · see citing works
Fluconazole Susceptibility of Vaginal Isolates Obtained from Women with Complicated Candida Vaginitis: Clinical Implications
Sobel, J. D., Zervos, M., Reed, B. D., Hooton, T. M., Soper, D. E., Nyirjesy, P., Heine, M. W., Willems, J., & Panzer, H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.34-38.2003 · Cited by 118 · see citing works
Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects and therapy
Sobel, J. D., Vazquez, J., Lynch, M., Meriwether, C., & Zervos, M. J. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/16.1.93 · Cited by 117 · see citing works
Infection through structured polymicrobial Gardnerella biofilms (StPM-GB).
Swidsinski, A. V., Loening-Baucke, V. A., Mendling, W., Dörffel, Y., Schilling, J., Halwani, Z., Jiang, X., Verstraelen, H., & Swidsinski, S. (2014) · PubMed · doi:10.14670/hh-29.10.567 · Cited by 113 · see citing works
Self-citation
A localized vaginal allergic response in women with recurrent vaginitis
Witkin, S. S., Jeremias, J., & Ledger, W. J. (1988) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(88)90909-8 · Cited by 113 · see citing works
Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole
Mastroiacovo, P., Mazzone, T., Botto, L. D., Serafini, M. A., Finardi, A., Caramelli, L., & Fusco, D. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70119-9 · Cited by 111 · see citing works
Pathogenicity determinants of Candida
Ghannoum, M. A., & Abu‐Elteen, K. H. (1990) · Mycoses · doi:10.1111/myc.1990.33.6.265 · Cited by 109 · see citing works
Prevalence of Candida glabrata and Its Response to Boric Acid Vaginal Suppositories in Comparison With Oral Fluconazole in Patients With Diabetes and Vulvovaginal Candidiasis
Ray, D., Goswami, R., Banerjee, U., Dadhwal, V., Goswami, D., Mandal, P., Sreenivas, V., & Kochupillai, N. (2007) · Diabetes Care · doi:10.2337/dc06-1469 · Cited by 105 · see citing works
Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush)
Denison, H. J., Worswick, J., Bond, C. M., Grimshaw, J., Mayhew, A., Ramadoss, S. G., Robertson, C., Schaafsma, M. E., & Watson, M. C. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002845.pub3 · Cited by 104 · see citing works
Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy
Goswami, D., Goswami, R., Banerjee, U., Dadhwal, V., Miglani, S., Lattif, A. A., & Kochupillai, N. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.03.005 · Cited by 104 · see citing works
A 5‐year (2000–2004) epidemiological survey of Candida and non‐Candida yeast species causing vulvovaginal candidiasis in Graz, Austria
Paulitsch‐Fuchs, A. H., Weger, W., Ginter‐Hanselmayer, G., Marth, E., & Buzina, W. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01284.x · Cited by 102 · see citing works
Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an open-label pilot randomized controlled trial
Roberts, C. L., Rickard, K., Kotsiou, G., & Morris, J. M. (2011) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-11-18 · Cited by 100 · see citing works
Effect of Antibiotics on Vulvovaginal Candidiasis: A MetroNet Study
Xu, J., Schwartz, K., Bartoces, M. G., Monsur, J. C., Severson, R. K., & Sobel, J. D. (2008) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2008.04.070169 · Cited by 100 · see citing works
Vaginitis Due to Candida krusei: Epidemiology, Clinical Aspects, and Therapy
Singh, S., Sobel, J. D., Bhargava, P., Boikov, D. A., & Vazquez, J. A. (2002) · Clinical Infectious Diseases · doi:10.1086/343826 · Cited by 97 · see citing works
Nomenclature of fungal diseases: a report and recommendations from a sub-committee of the International Society for Human and Animal Mycology (ISHAM)
Odds, F. C., Arai, T., DiSalvo, A. F., Evans, E. G. V., Hay, R. J., Randhawa, H. S., Rinaldi, M. G., & Walsh, T. J. (1992) · Medical Mycology · doi:10.1080/02681219280000021 · Cited by 96 · see citing works
Accuracy of the Clinical Diagnosis of Vaginitis Compared With a DNA Probe Laboratory Standard
Lowe, N. K., Neal, J. L., & Ryan‐Wenger, N. A. (2009) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181909f63 · Cited by 95 · see citing works
Oestrogen, glycogen and vaginal candidiasis
Dennerstein, G., & Ellis, D. H. (2001) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2001.tb01238.x · Cited by 95 · see citing works
Role of Mannose‐Binding Lectin in the Innate Defense againstCandida albicans:Enhancement of Complement Activation, but Lack of Opsonic Function, in Phagocytosis by Human Dendritic Cells
Ip, W., & Lau, Y. (2004) · The Journal of Infectious Diseases · doi:10.1086/422397 · Cited by 92 · see citing works
Recent progress in vaccines against fungal diseases
Cassone, A., & Casadevall, A. (2012) · Current Opinion in Microbiology · doi:10.1016/j.mib.2012.04.004 · Cited by 90 · see citing works
Immunity in vaginal candidiasis
Fidel, P. L. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000160897.74492.a3 · Cited by 89 · see citing works
Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis
Auler, M. E., Morreira, D., Rodrigues, F. F. O., Ão, M. S. A., Margarido, P. F. R., Matsumoto, F. E., Silva, E. G., da Silva, B. C. M., Schneider, R. P., & Paula, C. R. (2010) · Medical Mycology · doi:10.3109/13693780902856626 · Cited by 89 · see citing works
Mannose‐binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis
Donders, G. G. G., Babula, O., Bellen, G., Linhares, I. M., & Witkin, S. S. (2008) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.01830.x · Cited by 88 · see citing works
Oral versus intra‐vaginal imidazole and triazole anti‐fungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): a systematic review
Watson, M. C., Grimshaw, J., Bond, C. M., Mollison, J., & Ludbrook, A. (2002) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2002.01142.x · Cited by 87 · see citing works
Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse
Rylander, E. (2004) · Sexually Transmitted Infections · doi:10.1136/sti.2003.004192 · Cited by 87 · see citing works
Effect of Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14 on the ability of Candida albicans to infect cells and induce inflammation
Martinez, R. C. R., Seney, S. L., Summers, K. L., Nomizo, A., Martinis, E. C. P. D., & Reid, G. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2009.00154.x · Cited by 86 · see citing works
Management of Recurrent Vulvo-Vaginal Candidosis as a Chronic Illness
Donders, G. G. G., Bellen, G., & Mendling, W. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000314022 · Cited by 83 · see citing works
Self-citation
Can intrauterine contraceptive devices be a Candida albicans reservoir?
Chassot, F., Negri, M., Svidzinski, A. E., Donatti, L., Peralta, R. M., Svidzinski, T. I. E., & Consolaro, M. E. L. (2008) · Contraception · doi:10.1016/j.contraception.2008.01.007 · Cited by 81 · see citing works
Candida africana and its closest relatives
Romeo, O., & Criseo, G. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01939.x · Cited by 78 · see citing works
Recurrent allergic vulvovaginitis: Treatment with Candida albicans allergen immunotherapy
Rigg, D., Miller, M. M., & Metzger, W. J. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90380-p · Cited by 75 · see citing works
Candida Albicans: The Estrogen Target for Vaginal Colonization
Tarry, W. F., Fisher, M., Shen, S., & Mawhinney, M. (2005) · Journal of Surgical Research · doi:10.1016/j.jss.2005.05.019 · Cited by 75 · see citing works
Key Note Lecture Review article Vulvovaginitis due to Candida glabrata. An emerging problem
Sobel, J. D. (1998) · Mycoses · doi:10.1111/j.1439-0507.1998.tb00594.x · Cited by 74 · see citing works
Vaginitis
Spinillo, A., Capuzzo, E., Egbe, T. O., Baltaro, F., Nicola, S., & Piazzi, G. (1995) · Obstetrics and Gynecology · doi:10.1016/0029-7844(95)00047-u · Cited by 72 · see citing works
A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism
Gaspard, U., Scheen, A., Endrikat, J., Buicu, C., Lefebvre, P., Gerlinger, C., & Heithecker, R. (2003) · Contraception · doi:10.1016/s0010-7824(02)00537-1 · Cited by 72 · see citing works
Candida Transmission and Sexual Behaviors as Risks for a Repeat Episode of Candida Vulvovaginitis
Reed, B. D., Zazove, P., Pierson, C. L., Gorenflo, D. W., & Horrocks, J. (2003) · Journal of Women s Health · doi:10.1089/154099903322643901 · Cited by 68 · see citing works
Association of Recurrent Vaginal Candidiasis and Secretory ABO and Lewis Phenotype
Chaim, W., Foxman, B., & Sobel, J. D. (1997) · The Journal of Infectious Diseases · doi:10.1086/517314 · Cited by 68 · see citing works
“Not thrush again!” Women's experience of post‐antibiotic vulvovaginitis
Pirotta, M. V., Gunn, J. M., & Chondros, P. (2003) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05418.x · Cited by 66 · see citing works
Treatment of Vulvovaginal Candidiasis in Patients With Diabetes
Bohannon, N. J. V. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.451 · Cited by 66 · see citing works
Treatment of Non-Albicans Candida Vaginitis with Amphotericin B Vaginal Suppositories
Phillips, A. J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.03.034 · Cited by 66 · see citing works
Prevalence of Vaginal Colonization by Drug‐ResistantCandidaSpecies in College‐Age Women with Previous Exposure to Over‐the‐Counter Azole Antifungals
Mathema, B., Cross, E., Dun, E., Park, S., Bedell, J., Slade, B., Williams, M., Riley, L., Chaturvedi, V., & Perlin, D. S. (2001) · Clinical Infectious Diseases · doi:10.1086/322600 · Cited by 65 · see citing works
Impaired tolerance for glucose in women with recurrent vaginal candidiasis
Donders, G. G. G., Prenen, H., Verbeke, G. N., & Reybrouck, R. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.126285 · Cited by 63 · see citing works
Distribution of Candida species in women with vulvovaginal symptoms and their association with different ages and contraceptive methods
Çetin, M., Ocak, S., Güngören, A., & Hakverdi, A. U. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540601148491 · Cited by 62 · see citing works
Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis.
Sobel, J. D. (1985) · PubMed · Cited by 62 · see citing works
We Should Monitor Human Fecundity, But How? A Suggestion for a New Method That May Also Be Used to Identify Determinants of Low Fecundity
Olsen, J., & Andersen, P. K. (1999) · Epidemiology · doi:10.1097/00001648-199907000-00013 · Cited by 61 · see citing works
Asymptomatic trichomonas and candida colonization and pregnancy outcome
Hay, P., & Czeizel, A. E. (2007) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2007.02.002 · Cited by 61 · see citing works
Sterol biosynthesis inhibitors
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90024-3 · Cited by 61 · see citing works
Microbial flora associated with Candida albicans vulvovaginitis
Auger, P., & Joly, J. (1980) · Obstetrics and Gynecology · doi:10.1097/00006250-198003000-00029 · Cited by 59 · see citing works
Association between atopy and recurrent vaginal candidiasis
Neves, N. A., Carvalho, L. P., de Oliveira, M. A. M., Giraldo, P. C., Bacellar, O., Cruz, Ã. A., & Carvalho, E. M. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02891.x · Cited by 58 · see citing works
Co‐treatment of the male partner in vaginal candidosis: a double‐blind randomized control study
Bisschop, M. P. J. M., Merkus, J. M. W. M., Scheygrond, H., & Cutsem, J. V. (1986) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1986.tb07818.x · Cited by 58 · see citing works
Preterm birth reduction after clotrimazole treatment during pregnancy
Czeizel, A. E., Fladung, B., & Vargha, P. (2004) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.02.011 · Cited by 58 · see citing works
Diagnosis of Vaginal Discharge by Wet Mount Microscopy: A Simple and Underrated Method
Mylonas, I. G., & Bergauer, F. (2011) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e31822bdf31 · Cited by 58 · see citing works
Relationship between clinical diagnosis of recurrent vulvovaginal candidiasis and detection of Candida species by culture and polymerase chain reaction
Weissenbacher, T., Witkin, S. S., Ledger, W. J., Tolbert, V., Gingelmaier, A., Scholz, C., Weissenbacher, E. R., Friese, K., & Mylonas, I. G. (2008) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-008-0681-9 · Cited by 56 · see citing works
Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy
Shahid, Z., & Sobel, J. D. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.03.021 · Cited by 55 · see citing works
Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush)
Nurbhai, M., Grimshaw, J., Watson, M. C., Bond, C. M., Mollison, J., & Ludbrook, A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002845.pub2 · Cited by 54 · see citing works
Prevention and Treatment of Vulvovaginal Candidiasis Using Exogenous Lactobacillus
Jeavons, H. S. (2003) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1177/0884217503253439 · Cited by 51 · see citing works
Signs of chronic stress in women with recurrent candida vulvovaginitis
Ehrström, S., Kornfeld, D., Thuresson, J., & Rylander, E. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.03.068 · Cited by 50 · see citing works
Prevalence and management of non-albicans vaginal candidiasis
Hetticarachchi, N., Ashbee, H. R., & Wilson, J. D. (2010) · Sexually Transmitted Infections · doi:10.1136/sti.2009.040386 · Cited by 50 · see citing works
Scanning electron microscope study ofCandida albicansinvasion of cultured human cervical epithelial cells
Farrell, S. M., Hawkins, D. F., & Ryder, T. A. (1983) · Medical Mycology · doi:10.1080/00362178385380391 · Cited by 47 · see citing works
No Teratogenic Effect after Clotrimazole Therapy during Pregnancy
Czeizel, A. E., Tóth, M., & Rockenbauer, M. (1999) · Epidemiology · doi:10.1097/00001648-199907000-00016 · Cited by 47 · see citing works
Identification of a17β-estradiol binding protein inCandida albicans andCandida (Torulopsis) glabrata
Powell, B. L., Frey, C. L., & Drutz, D. J. (1984) · Experimental Mycology · doi:10.1016/0147-5975(84)90054-9 · Cited by 46 · see citing works
The pill does not cause ‘thrush’
Davidson, F., & Oates, J. (1985) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1985.tb04873.x · Cited by 46 · see citing works
An Outline of the Role of Anti-Candida Antibodies Within the Context of Passive Immunization and Protection from Candidiasis
Cassone, A., Bernardis, F. D., & Torososantucci, A. (2005) · Current Molecular Medicine · doi:10.2174/1566524054022549 · Cited by 45 · see citing works
New Approaches in the Development of a Vaccine for Mucosal Candidiasis: Progress and Challenges
Vecchiarelli, A., Pericolini, E., Gabrielli, E., & Pietrella, D. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00294 · Cited by 43 · see citing works
Hyposensitisation in the management of recurring vaginal candidiasis.
Rosedale, N., & Browne, K. (1979) · PubMed · Cited by 42 · see citing works
Stress as a cause of chronic recurrent vulvovaginal candidosis and the effectiveness of the conventional antimycotic therapy
Meyer, H., Goettlicher, S., & Mendling, W. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01235.x · Cited by 42 · see citing works
Self-citation
Relationship between recurrent vulvovaginal candidosis and immune mediators in vaginal fluid
Weissenbacher, T. M., Witkin, S. S., Gingelmaier, A., Scholz, C., Friese, K., & Mylonas, I. G. (2009) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2009.01.010 · Cited by 42 · see citing works
Epidemiologische Untersuchungen zum Vorkommen von Hefepilzen bei Kindern und deren Müttern*
Blaschke-Hellmessen, R. (1968) · Mycoses · doi:10.1111/j.1439-0507.1968.tb03398.x · Cited by 42 · see citing works
Antimicrobial Activity of Dequalinium Chloride against Leading Germs of Vaginal Infections
Casa, V. D., Noll, H., Gonser, S., Grob, P., Graf, F., & Pohlig, G. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1299954 · Cited by 40 · see citing works
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)
Thoden, J., Potthoff, A. V., Bogner, J. R., Brockmeyer, N. H., Esser, S., Grabmeier‐Pfistershammer, K., Haas, B. J., Hahn, K., Härter, G., Hartmann, M., et al. (2013) · Infection · doi:10.1007/s15010-013-0504-1 · Cited by 40 · see citing works
Investigations by Cell-Mediated Immunologic Tests and Therapeutic Trials With Thymopentin in Vaginal Mycoses
Mendling, W., & Koldovsky, U. (1996) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/s1064744996000439 · Cited by 40 · see citing works
Self-citation
Biased Genotype Distributions ofCandida albicansStrains Associated with Vulvovaginal Candidosis and Candidal Balanoposthitis in China
Li, J., Fan, S., Liu, X., Li, D. M., Nie, Z., Li, F., Lin, H., Huang, W., Zong, L., Jin, J., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/592249 · Cited by 39 · see citing works
Nine male cases of tinea genitalis
Romano, C., Ghilardi, A., & Papini, M. (2005) · Mycoses · doi:10.1111/j.1439-0507.2005.01127.x · Cited by 38 · see citing works
Vaginal Candida parapsilosis: pathogen or bystander?
Nyirjesy, P., Alexander, A. B., & Weitz, M. V. (2005) · PubMed · doi:10.1080/10647440400025603 · Cited by 38 · see citing works
Recurrent Vulvovaginal Candidiasis
Trumbore, D. J., & Sobel, J. D. (1986) · Obstetrics and Gynecology · doi:10.1097/00006250-198606000-00012 · Cited by 38 · see citing works
Itraconazole vs fluconazole for the treatment of uncomplicated acute vaginal and vulvovaginal candidiasis in nonpregnant women: a metaanalysis of randomized controlled trials
Pitsouni, E. I., Iavazzo, C. R., & Falagas, M. E. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.10.786 · Cited by 37 · see citing works
Monthly itraconazole versus classic homeopathy for the treatment of recurrent vulvovaginal candidiasis: a randomised trial
Witt, A., Kaufmann, U., Bitschnau, M., Tempfer, C. M., Özbal, A., Haytouglu, E., Gregor, H., & Kiss, H. (2009) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02262.x · Cited by 37 · see citing works
Vaginal Candida parapsilosis: Pathogen or Bystander?
Nyirjesy, P., Alexander, A. B., & Weitz, M. V. (2005) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2005/401530 · Cited by 37 · see citing works
A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten®, two formats) with oral single dose fluconazole (Diflucan®) in vulvovaginal mycoses
Mendling, W., Krauss, C., & Fladung, B. (2004) · Mycoses · doi:10.1111/j.1439-0507.2004.00970.x · Cited by 36 · see citing works
Self-citation
Yeast Infections — Human Genetics on the Rise
Holland, S. M., & Vinh, D. C. (2009) · New England Journal of Medicine · doi:10.1056/nejme0907186 · Cited by 35 · see citing works
Systemic and mucosal immunization withCandida albicanshsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis
Raška, M., Běláková, J., Raška, M., Běláková, J., Horynová, M., Křupka, M., Novotný, J., Šebestová, M., & Weigl, E. (2008) · Medical Mycology · doi:10.1080/13693780701883508 · Cited by 34 · see citing works
Treatment of Vaginal Candidosis with Natamycin and Effect of Treating the partner at the same time
Buch, A., & Christensen, E. S. (1982) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348209156578 · Cited by 32 · see citing works
The serum levels of calcium, magnesium, iron and zinc in patients with recurrent vulvovaginal candidosis during attack, remission and in healthy controls
Špaček, J., Jílek, P., Buchta, V., Förstl, M., Hronek, M., & Holečková, M. (2005) · Mycoses · doi:10.1111/j.1439-0507.2005.01164.x · Cited by 32 · see citing works
Vaginose, Vaginitis, Zervizitis und Salpingitis
Mendling, W. (2006) · Springer eBooks · doi:10.1007/978-3-540-30096-0 · Cited by 31 · see citing works
Self-citation
Vaginal heat shock protein expression in symptom-free women with a history of recurrent vulvovaginitis
Giraldo, P. C., Neuer, A., Korneeva, I., Ribeiro-Filho, A., Simões, J. A., & Witkin, S. S. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70248-6 · Cited by 30 · see citing works
The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis.
Fong, I. W. (1992) · Sexually Transmitted Infections · doi:10.1136/sti.68.6.374 · Cited by 30 · see citing works
Voraussetzungen für eine effektive Therapie chronisch rezidivierender Vaginalcandidosen
Kunzelmann, V., Tietz, H. ‐., Rossner, D., Czaika, V. A., Hopp, M., Schmalreck, A., & Sterry, W. (1996) · Mycoses · doi:10.1111/j.1439-0507.1996.tb00508.x · Cited by 29 · see citing works
Topical antiseptics as an alternative in the treatment of acute vulvovaginal candidosis
Friese, K., Neumann, G., & Siebert, J. (2003) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-002-0368-6 · Cited by 29 · see citing works
Vaginal yeasts in the era of "over the counter" antifungals
Walker, P. P. (2000) · Sexually Transmitted Infections · doi:10.1136/sti.76.6.437 · Cited by 29 · see citing works
Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet.
Roth, A. C., Milsom, I., Forssman, L., & Wåhlén, P. (1990) · Sexually Transmitted Infections · doi:10.1136/sti.66.5.357 · Cited by 28 · see citing works
Investigations by cell-mediated immunologic tests and therapeutic trials with thymopentin in vaginal mycoses
Mendling, W., & Koldovsky, U. (1996) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1002/(sici)1098-0997(1996)4:4 · Cited by 28 · see citing works
Self-citation
Potential role of probiotic bacteria in the treatment and prevention of localised candidosis
Mailänder‐Sánchez, D., Wagener, J., & Schaller, M. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01967.x · Cited by 27 · see citing works
Multilocus sequence typing of Candida africana from patients with vulvovaginal candidiasis in New Delhi, India
Sharma, C., Muralidhar, S., Xu, J., Meis, J. F. G. M., & Chowdhary, A. (2014) · Mycoses · doi:10.1111/myc.12193 · Cited by 26 · see citing works
Protist tubulins: new arrivals, evolutionary relationships and insights to cytoskeletal function
Gull, K. (2001) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00230-7 · Cited by 26 · see citing works
Candida albicans allergen immunotherapy in recurrent vaginal candidiasis.
Moraes, P., Goiaba, S. D. L., & Taketomi, E. A. (2001) · PubMed · Cited by 25 · see citing works
Recurrent vulvovaginal candidiasis: vaginal epithelial cell susceptibility to Candida albicans adherence.
Trumbore, D. J., & Sobel, J. D. (1986) · PubMed · Cited by 23 · see citing works
Antimicrobial Topical Agents Used in the Vagina
Tirri, B. F. (2011) · Current problems in dermatology · doi:10.1159/000321047 · Cited by 23 · see citing works
Two Cases of Vaginitis Caused by Itraconazole-Resistant Saccharomyces cerevisiae and a Review of Recently Published Studies
Savini, V., Catavitello, C., Manna, A., Talia, M., Febbo, F., Balbinot, A., D’Antonio, F., Bonaventura, G. D., Celentano, C., Liberati, M., et al. (2008) · Mycopathologia · doi:10.1007/s11046-008-9119-y · Cited by 22 · see citing works
Subpartale Übertragung von Candida und ihre Konsequenzen
Blaschke‐Hellmessen, R. (1998) · Mycoses · doi:10.1111/j.1439-0507.1998.tb00598.x · Cited by 22 · see citing works
Self-reported yeast symptoms compared with clinical wet mount analysis and vaginal yeast culture in a specialty clinic setting.
Hoffstetter, S., Barr, S. P., LeFevre, C., Leong, F. C., & Leet, T. L. (2008) · PubMed · Cited by 21 · see citing works
Immunotherapeutic approaches to enhance protective immunity againstCandidavaginitis
Wozniak, K. L., Palmer, G. E., Kutner, R. H., & Fidel, P. L. (2005) · Medical Mycology · doi:10.1080/13693780500096898 · Cited by 21 · see citing works
[Pharmacokinetics of imidazole-antimycotics (author's transl)].
Plempel, M. (1980) · PubMed · Cited by 21 · see citing works
Die Salzsaure‐Toleranz von Candida albicans
Meinhof, W. (1974) · Mycoses · doi:10.1111/j.1439-0507.1974.tb04509.x · Cited by 20 · see citing works
Single-Dose Miconazole Nitrate Vaginal Ovule in the Treatment of Vulvovaginal Candidiasis: Two Single-Blind, Controlled Studies Versus Miconazole Nitrate 100 mg Cream for 7 Days
Upmalis, D. H., Cone, F. L., Lamia, C. A., Reisman, H., Rodriguez-Gomez, G., Gilderman, L. I., & Bradley, L. (2000) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/15246090050020745 · Cited by 18 · see citing works
Utilization of siderophores by Candida albicans
Ismail, A., & Lupan, D. M. (1986) · Mycopathologia · doi:10.1007/bf00436669 · Cited by 18 · see citing works
Pharmakokinetik der Imidazol‐Antimykotika*)
Plempel, M. (1980) · Mycoses · doi:10.1111/j.1439-0507.1980.tb02551.x · Cited by 16 · see citing works
Is more than one application of an antifungal necessary in the treatment of acute vaginal candidiasis?
Cohen, L. (1985) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(85)80011-9 · Cited by 16 · see citing works
The development of evidence-based guidelines for over-the-counter treatment of vulvovaginal candidiasis.
Bond, C. M., & Watson, D. C. (2003) · Pharmacy World & Science · doi:10.1023/a:1024842712675 · Cited by 15 · see citing works
Three-Day Combination Treatment for Vulvovaginal Candidosis with 200 mg Clotrimazol Vaginal Suppositories and Clotrimazol Cream for the Vulva is Significantly Better than Treatment with Vaginal Suppositories Alone – an Earlier, Multi-Centre, Placebo-Controlled Double Blind Study
Mendling, W., & Schlegelmilch, R. (2014) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0034-1368243 · Cited by 14 · see citing works
Self-citation
The glyoxylate cycle enzyme activities in the pathogenic isolates of Candida albicans obtained from HIV/AIDS, diabetic and burn patients
Lattif, A. A., Prasad, R., Banerjee, U., Gupta, N., Mohammad, S., & Baquer, N. (2006) · Mycoses (Berlin) · doi:10.1111/j.1439-0507.2006.01192.x · Cited by 14 · see citing works
Vergleich der Stammspezifität von Hefepilzen verschiedener Lokalisation bei Frauen mit Vaginalcandidosen
Mendling, W., Gutschmidt, J., Gantenberg, R., Andrade, M. P. D., & Schönian, G. (1998) · Mycoses · doi:10.1111/j.1439-0507.1998.tb00596.x · Cited by 13 · see citing works
Self-citation
The Use of Data Set of the Hungarian Case-Control Surveillance of Congenital Abnormalities for Evaluation of Birth Outcomes beyond Birth Defects
Czeizel, A. E., Puhó, E., & Kazy, Z. (2007) · Central European Journal of Public Health · doi:10.21101/cejph.a3440 · Cited by 13 · see citing works
Terminologie der Humanmykosen/ Terminology of Human Mycoses
Loeffler, W. (1983) · Mycoses · doi:10.1111/j.1439-0507.1983.tb03224.x · Cited by 13 · see citing works
Doppelblind-Vergleichsstudie mit Ciclopiroxolamin- und Miconazol-Vaginalcreme bei uilvovaginaler Candidose
Wajnberg, M., & Wajnberg, A. (2009) · Mycoses · doi:10.1111/j.1439-0507.1981.tb01827.x · Cited by 12 · see citing works
Die Torulopsidose1in der Frauenheilkunde2
Mendling, W. (1984) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-2008-1036308 · Cited by 12 · see citing works
Self-citation
Terminology of human mycoses. Nomenclature of mycotic diseases of man. List of accepted German terms translated, arranged and published, together with comments, for the International Society for Human and Animal Mycology (ISHAM).
Loeffler, W. (1983) · PubMed · Cited by 11 · see citing works
[Evaluation of the efficacity and speed of action of sertaconazole nitrate suppository and cream combined treatment for vulvovaginal candidiasis].
Quéreux, C., Gelas, B., Chevallier, T., Petit, F., & Micheletti, M. C. (2000) · PubMed · Cited by 11 · see citing works
Die vaginale Kolonisation durch Candidaarten unter besonderer Berücksichtigung von Candida dubliniensis
Mendling, W., Niemann, D., & Tintelnot, K. (2007) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-2007-965681 · Cited by 9 · see citing works
Self-citation
Epidemiology and the Prevention of Peripartal Mycoses
Schnell, J. D. (2009) · Chemotherapy · doi:10.1159/000238156 · Cited by 9 · see citing works
Candidaautovaccination in the treatment of vulvovaginalCandidainfections
Rusch, K., & Schwiertz, A. (2007) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2006.11.003 · Cited by 9 · see citing works
Das Verhalten von Spro�pilzen am nicht verhornenden Plattenepithel
Schnell, J. D., & Voigt, W.-H. (1974) · Archives of Gynecology and Obstetrics · doi:10.1007/bf00668025 · Cited by 9 · see citing works
Veränderungen der Ultrastruktur von Candida albicans unter der Einwirkung von Polyenantibiotika: Ultrastructural Changes in Candida Albicans caused by Polyene Antibiotics
Scheklakow, N. D., Delektorski, W. W., & Golodova, O. A. (2009) · Mycoses · doi:10.1111/j.1439-0507.1981.tb01851.x · Cited by 9 · see citing works
[Ultrastructural changes in Candida albicans caused by polyene antibiotics (author's transl)].
Scheklakow, N. D., Delektorski, W. W., & Golodova, O. A. (1981) · PubMed · Cited by 7 · see citing works
Die Vakzination mit inaktivierten Laktobazillen oder mit Heliotherapie kann die Lebensqualität von Frauen mit chronisch rezidivierender vulvovaginaler Kandidose verbessern – Eine prospektive 3-armige randomisierte Studie
Mendling, W., & Birkner, V. (2011) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0031-1280203 · Cited by 7 · see citing works
Self-citation
The Role of Humoral Immunity against Vaginal Candida Infection
Bernardis, F. D., Boccanera, M., & Cassone, A. (2005) · Springer eBooks · doi:10.1007/0-387-25445-5_17 · Cited by 6 · see citing works
Candida glabrata
Tietz, H. (2012) · Der Hautarzt · doi:10.1007/s00105-012-2377-0 · Cited by 5 · see citing works
Kommentar zum vorstehenden Beitrag von J. D. Sobel
Tietz, H. (1998) · Mycoses · doi:10.1111/j.1439-0507.1998.tb00595.x · Cited by 5 · see citing works
Die Hormonspirale als Risikofaktor für chronische Infektionen
von Zglinicki, W. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-9312 · Cited by 1 · see citing works

Flagged first, then by citations

Research works printed but not linked: 25

Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal com- plaints. JAMA 2004; 291: 1368-79.
Davidson F, Mould RF. Recurrent vaginal candidosis in women and the effect of intermittent prophylactic treatment. BJ Vener Dis 1978; 54: 176-83.
Farrell SM, Hawkins DF, Ryder TT. Scanning electron microscope study of Candida albicans, invasion of cultural human cervical epi- thelial cells. Sabouraudia 1983; 25: 251-4.
Ferwerda B, Ferwerda B, Platinga TS et al. Human lectin-1 defi- ciency and mucocutaneous fungal infections. N Engl J Med 2009; 361: 1760-7.
Jeavons HS. Prevention and treatment of vulvovaginal candidosis using exogenous lactobacilli. J Obstet Gynecol Neonatal Nurs 2003; 32: 287-96.
Li J, Fan SR, Liu XP et al. Biased genotype distributions of Candida albicans strains associated with vulvovaginal candidosis and candi- dal balanoposthitis in China. Clin Infect Dis 2008; 47: 1119-25.
Loeffler W. Terminologie der Humanmykosen. Mykosen 1983; 26: 346.
Mendling W. Die Torulopsidose in der Frauenheilkunde. Geburtsh Frauenheilk 1984; 44: 583-6.
Mendling W, Koldovsky U. Investigations by cell-mediated immuno- logic tests of therapeutic trials with thymopentin in vaginal myco- ses. Inf Dis Obstet Gynecol 1996a; 4: 225-31.
Mendling W, Niemann D, Tintelnot K. Vaginal Colonisation with Candida Species with Special Focus on Candida dubliniensis. A Pro- spective Study. Geburtsh Frauenheilk 2007; 67: 1132-7.
Mendling W, Schlegelmilch R. Die 3t€ agige Kombinationsbehand- lung der Vulvovaginalkandidose mit Clotrimazol 200 mg Vaginalta- bletten und Clotrimazol Cr eme f€ ur die Vulva ist significant besser als die mit Vaginaltabletten allein. Eine € altere multizentrische, Pla- zebo-kontrollierte Doppelblindstudie und ihre Bedeutung f€ ur Thera- pieempfehlungen. Geburtsh Frauenheilk 2014; 74: 355-60.
M€ uller J, Nold B, Kubitza D, Baumert J. Quantitative Untersuchun- gen € uber die D€ oderlein-Flora gesunder sowie mykosekranker Prob- andinnen unter lokaler Isoconazol-Nitrat-Therapie. In: Seeliger HPR (ed) Gyno -Travogen, Monographie Excerpta Medica. Amsterdam: Oxford Princeton 1981: 81-93.
Niewerth M, Kunze D, Seibold M, Schaller M, Korting HC, Hube B. Ciclopirox olamine treatment affects the expression pattern of metabolism proteins, and drug resistance factors. Antimicrob Agents Chemother 2003; 47: 1805-17.
Powell BL. Identification of a 173 -estradiol -binding protein in Candida albicans and Candida (Torulopsis) glabrata. Exp Mycology 1984; 8: 304. 108
Reed BD, Zazone P, Pierson LL, Gorenflo DW, Horreocks J. Candida transmission and sexual behaviour as risk for a repeated episode of Candida vulvovaginitis. J Womens Health (Larchmt) 2003; 12: 979- 89. 112
Rusch K, Schwiertz A. Candida autovaccination in the treatment of vulvovaginal Candida infections. Int J Gynecol Obstet 2007; 96: 130. 122
Scheklakow ND, Deletorski WW, Goldoa OA. Ver€ anderungen der Ultrastruktur von Candida albicans unter Einwirkung von Polyen- Antibiotika. Mykosen 1980; 24: 140-52. 125
Schnell JD, Voigt WH. Das Verhalten von Sprosspilzen am nicht verhornenden Plattenepithel. Arch Gynaekol 1974; 217: 377-82. 127
Spinillo A, Capuzzo E, Egbe TO, Baltaro P, Nicola S, Piazzi G. Torul- opsis glabrata vaginitis. Obstet Gynecol 1995; 85: 993-8. 139
Wajnberg M, Wajnberg A. Doppelblind-Vergleichsstudie mit Cic- lopyroxolamin-und Miconazol-Vaginalcreme bei vulvovaginaler Kandidose. Mykosen 1981; 24: 721-30. 149
Watson MC, Grimshaw JM, Bond CM, Mollison J, Ludbrook A. Oval versus intravaginal imidazole and triazole antifungal treatment of uncomplicated Candidiasis (thrush): a systemic review. BJOG 2002; 109: 85-89. 151
Wilson C. Recurrent vulvovaginal candidiasis; an overview of tradi- tional and alternative therapies. Adv Nurse Pract. 2005; 13: 24-29. 155
Witkin SS, Giraldo P, Linhares D. New insights into the immune pathogenesis of recurrent vulvovaginal candidiasis. Int J Gynecol Obestet 2000; 3: 114-8. 157
Young GL, Jewell D. Topical treatment for vaginal candidiasis (thrush in pregnancy) (review). The Cochrane Database of systematic Reviews 2001; 4:CD 000225. 161
Von Zglinicki W. Die Hormonspirale als Ursache f€ ur chronische Infektionen. Dissertation (Prof. HJ Tietz), Charit e 2011.

Sorted by citations

2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge
Sherrard, J., Wilson, J., Donders, G., Mendling, W., & Jensen, J. S. (2018) · International Journal of STD & AIDS · doi:10.1177/0956462418785451 · Cited by 297 · see citing works
Self-citation
Guideline: Vulvovaginal Candidosis (AWMF 015/072, Level S2k)
Farr, A., Effendy, I., Frey Tirri, B., Hof, H., Mayser, P., Petricevic, L., Ruhnke, M., Schaller, M., Schaefer, A. P. A., Sustr, V., et al. (2021) · Mycoses · doi:10.1111/myc.13248 · Cited by 184 · see citing works
Self-citation
Recurrent vulvovaginal candidiasis
Blostein, F., Levin-Sparenberg, E., Wagner, J., & Foxman, B. (2017) · Annals of Epidemiology · doi:10.1016/j.annepidem.2017.08.010 · Cited by 180 · see citing works
Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon
Ghaddar, N., Anastasiadis, E., Halimeh, R., Ghaddar, A., Dhar, R., Alfouzan, W. A., Yusef, H., & Chaar, M. E. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-019-4736-2 · Cited by 103 · see citing works
Probiotics and vaginal microecology: fact or fancy?
Buggio, L., Somigliana, E., Borghi, A., & Vercellini, P. (2019) · BMC Women s Health · doi:10.1186/s12905-019-0723-4 · Cited by 101 · see citing works
Extracellular proteinases of Candida species pathogenic yeasts
Rapala‐Kozik, M., Bochenska, O., Zajac, D., Karkowska‐Kuleta, J., Gogol, M., Zawrotniak, M., & Kozik, A. (2018) · Molecular Oral Microbiology · doi:10.1111/omi.12206 · Cited by 94 · see citing works
Randomised Clinical Trial in Women with Recurrent Vulvovaginal Candidiasis: Efficacy of Probiotics and Lactoferrin as Maintenance Treatment
Russo, R., Superti, F., Karadja, E., & De Seta, F. (2019) · Mycoses · doi:10.1111/myc.12883 · Cited by 94 · see citing works
Current Aspects in the Biology, Pathogeny, and Treatment of Candida krusei, a Neglected Fungal Pathogen
Gómez-Gaviria, M., & Mora-Montes, H. M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s247944 · Cited by 88 · see citing works
Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods
Satora, M., Grunwald, A., Zaremba, B., Frankowska, K., Żak, K., Tarkowski, R., & Kułak, K. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165376 · Cited by 84 · see citing works
Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303)
Schwebke, J. R., Sobel, R., Gersten, J. K., Sussman, S. A., Lederman, S. N., Jacobs, M. A., Chappell, B. T., Weinstein, D. L., Moffett, A. H., Azie, N. E., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab750 · Cited by 82 · see citing works
Recurrent vulvovaginal candidiasis: A review of guideline recommendations
Matheson, A., & Mazza, D. (2017) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12592 · Cited by 68 · see citing works
Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam
Ánh, Đ. N., Hung, D. N., Tien, T. V., Dinh, V. N., Son, V. T., Luong, N. V., Van, N. T. T., Quỳnh, N. T. N., Tuấn, N. V., Tuấn, L. Q., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06192-7 · Cited by 67 · see citing works
Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches
Chew, S. Y., & Than, L. T. L. (2016) · Mycoses · doi:10.1111/myc.12455 · Cited by 63 · see citing works
Guidelines for the management of dermatomycosis (2019)
Mochizuki, T., Tsuboi, R., Iozumi, K., Ishizaki, S., Ushigami, T., Ogawa, Y. S., Kaneko, T., Kawai, M., Kitami, Y., Kusuhara, M., et al. (2020) · The Journal of Dermatology · doi:10.1111/1346-8138.15618 · Cited by 61 · see citing works
Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo‐controlled superiority study (VANISH 306)
Sobel, R., Nyirjesy, P., Ghannoum, M. A., Delchev, D., Azie, N., Angulo, D., Harriott, I., Borroto–Esoda, K., & Sobel, J. D. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16972 · Cited by 54 · see citing works
Vulvar Pruritus—Causes, Diagnosis and Therapeutic Approach
Woelber, L. L., Prieske, K., Mendling, W., Schmalfeldt, B., Tietz, H., & Jaeger, A. (2020) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2020.0126 · Cited by 45 · see citing works
Self-citation
Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis
Zhang, X., Li, T., Chen, X., Wang, S., & Liu, Z. (2018) · BMC Microbiology · doi:10.1186/s12866-018-1316-3 · Cited by 43 · see citing works
Clotrimazole for Vulvovaginal Candidosis: More Than 45 Years of Clinical Experience
Mendling, W., Shazly, M. A. E., & Zhang, L. (2020) · Pharmaceuticals · doi:10.3390/ph13100274 · Cited by 43 · see citing works
Self-citation
Isolation, molecular identification, and antifungal susceptibility profiles of vaginal isolates of Candida species.
Rezaei‐Matehkolaei, A., Shafiei, S., & Mahmoudabadi, A. Z. (2016) · PubMed Central · Cited by 41 · see citing works
Recent Advances in Nanosystems and Strategies for Vaginal Delivery of Antimicrobials
Chindamo, G., Sapino, S., Peira, E., Chirio, D., & Gallarate, M. (2021) · Nanomaterials · doi:10.3390/nano11020311 · Cited by 41 · see citing works
Antimicrobial photodynamic therapy as a new approach for the treatment of vulvovaginal candidiasis: preliminary results
de Santi, M. E. S. O., Prates, R. A., França, C. M., Lopes, R. G., Sousa, A. S., Ferreira, L. R., Bussadori, S. K., Fernandes, A. U., & Deana, A. M. (2018) · Lasers in Medical Science · doi:10.1007/s10103-018-2557-y · Cited by 39 · see citing works
Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management
Rodríguez‐Cerdeira, C., González-Cespón, J. L., Martínez-Herrera, E. O., Carnero-Gregorio, M., López-Bárcenas, A., Sergeev, A. Y., & Saunte, D. M. L. (2021) · Italian Journal of Dermatology and Venereology · doi:10.23736/s2784-8671.20.06580-3 · Cited by 38 · see citing works
Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis
Nyirjesy, P., Schwebke, J. R., Angulo, D. A., Harriott, I. A., Azie, N. E., & Sobel, J. D. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab841 · Cited by 38 · see citing works
The efficacy and safety of clotrimazole vaginal tablet vs. oral fluconazole in treating severe vulvovaginal candidiasis
Zhou, X., Li, T., Fan, S., Zhu, Y., Liu, X., Guo, X., & Liang, Y. (2016) · Mycoses · doi:10.1111/myc.12485 · Cited by 37 · see citing works
Amphotericin B-Loaded Poly(lactic-co-glycolic acid) Nanofibers: An Alternative Therapy Scheme for Local Treatment of Vulvovaginal Candidiasis
Souza, R. O., de Lima, T. H., Oréfice, R. L., Araújo, M. G. D. F., de Moura, S. A. L., de Magalhães, J. T., & da Silva, G. R. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.06.017 · Cited by 37 · see citing works
Clinicopathologic Diagnostic Criteria for Vulvar Lichen Planus
Day, T., Wilkinson, E. J., Rowan, D., & Scurry, J. (2020) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000532 · Cited by 35 · see citing works
Development and in vivo evaluation of chitosan-gel containing Mitracarpus frigidus methanolic extract for vulvovaginal candidiasis treatment
Campos, L. M., Lemos, A. S. D. O., da Cruz, L. F., Araújo, M. G. D. F., Botti, G. C. R. M., Júnior, J. L. R., Rocha, V. N., Denadai, Â. M. L., Silva, T. P. D., Tavares, G. D., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110609 · Cited by 33 · see citing works
Candidiasis vulvovaginal: una antigua enfermedad con nuevos desafíos
Miró, M. S., Rodríguez, E., Vigezzi, C., Icely, P. A., Araújo, M. G. D. F., Riera, F. O., Vargas, L., Abiega, C. D., Caeiro, J. P., & Sotomayor, C. E. (2017) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.11.006 · Cited by 31 · see citing works
The Antibiofilm Role of Biotics Family in Vaginal Fungal Infections
Boahen, A., Than, L. T. L., Loke, Y.-L., & Chew, S. Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.787119 · Cited by 31 · see citing works
Role of Echinocandins in Fungal Biofilm–Related Disease: Vascular Catheter–Related Infections, Immunomodulation, and Mucosal Surfaces
Katragkou, A., Roilides, E., & Walsh, T. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ746 · Cited by 31 · see citing works
Design of transfersomal nanocarriers of nystatin for combating vulvovaginal candidiasis; A different prospective
Hady, M. A., Darwish, A. B., Abdel-aziz, M. S., & Sayed, O. M. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.112304 · Cited by 29 · see citing works
Vulvovaginal Candidiasis in Pregnant Women and its Importance for Candida Colonization of Newborns
Zisova, L. G., Chokoeva, A. A., Amaliev, G. I., Petleshkova, P., Miteva-Katrandzhieva, T. M., Krasteva, M. B., Uchikova, E. H., Kouzmanov, A., & Ivanova, Z. (2016) · Folia Medica · doi:10.1515/folmed-2016-0018 · Cited by 29 · see citing works
Low intensity ultrasound-mediated drug-loaded nanoparticles intravaginal drug delivery: an effective synergistic therapy scheme for treatment of vulvovaginal candidiasis
Yang, M., Cao, Y., Zhang, Z., Guo, J., Hu, C., Wang, Z., & Du, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01800-x · Cited by 28 · see citing works
Antifungal susceptibility and molecular typing of 115Candida albicansisolates obtained from vulvovaginal candidiasis patients in 3 Shanghai maternity hospitals
Ying, C., Zhang, H., Tang, Z., Chen, H., Gao, J. Q., & Yue, C. (2015) · Medical Mycology · doi:10.1093/mmy/myv082 · Cited by 27 · see citing works
Urinary and genital infections in patients with diabetes: How to diagnose and how to treat
Soh, P. N., Vidal, F., Huyghe, É., Gourdy, P., Halimi, J., & Bouhanick, B. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.07.002 · Cited by 26 · see citing works
Safe and pragmatic use of sodium–glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement
Kalra, S., Ghosh, S. K., Aamir, A., Ahmed, M. T., Amin, M. F., Bajaj, S., Baruah, M., Bulugahapitiya, U., Das, A., Giri, M., et al. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.196029 · Cited by 26 · see citing works
Recurrent Vulvovaginal Candidosis and Cluster Analysis of Clinical Signs and Symptoms: A Laboratory-Based Investigation
Ignjatović, A., Arsić-Arsenijević, V. S., Golubović, M., Đenić, S., Momčilović, S., Trajković, A., Ranđelović, M., Ćirić, V. M., & Otašević, S. (2020) · Journal of Fungi · doi:10.3390/jof6030113 · Cited by 25 · see citing works
State-of-the-Art Review: Managing Vulvovaginal Candidiasis
Rautemaa‐Richardson, R., Sobel, J. D., Stone, N. R. H., Seta, F. D., Cassone, A., Vieira‐Baptista, P., Comar, M., Warris, A., & Roselletti, E. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf673 · Cited by 24 · see citing works
Effect of 2-Phenylethanol as Antifungal Agent and Common Antifungals (Amphotericin B, Fluconazole, and Itraconazole) on Candida Species Isolated from Chronic and Recurrent Cases of Candidal Vulvovaginitis
Majdabadi, N., Falahati, M., Heidarie-Kohan, F., Farahyar, S., Rahimi‐Moghaddam, P., Ashrafi‐Khozani, M., Razavi, T. D. A., & Mohammadnejad, S. (2018) · Assay and Drug Development Technologies · doi:10.1089/adt.2017.837 · Cited by 24 · see citing works
RAFT-derived polymethacrylates as a superior treatment for recurrent vulvovaginal candidiasis by targeting biotic biofilms and persister cells
Wu, X., Zhang, S., Xu, X., Shen, L., Xu, B., Qu, W., Zhuang, W., Locock, K., Deighton, M., & Qu, Y. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02592 · Cited by 23 · see citing works
Antifungal susceptibility profiles of Candida and non- albicans s pecies isolated from pregnant women: implications for emerging antimicrobial resistance in maternal health
Aboagye, G., Waikhom, S. D., Asiamah, E. A., Tettey, C. O., Mbroh, H. K., Smith, C., Osei, G. Y., Adjei, K. A., & Asmah, R. H. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00787-25 · Cited by 23 · see citing works
Does vaginal douching affect the type of candidal vulvovaginal infection?
Shaaban, O. M., Abbas, A. M., Moharram, A. M., Farhan, M., & Hassanen, I. H. (2015) · Medical Mycology · doi:10.1093/mmy/myv042 · Cited by 22 · see citing works
The use of 3 selected lactobacillary strains in vaginal probiotic gel for the treatment of acute candida vaginitis: a proof-of-concept study
Donders, G., Bellen, G., Oerlemans, E., Claes, I., Ruban, K., Henkens, T., Kiekens, F., & Lebeer, S. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03868-x · Cited by 20 · see citing works
Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504)
Palacios, S., Espadaler, J., Fernández-Moya, J. M., Prieto, C., & Salas, N. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2715-8 · Cited by 20 · see citing works
In vitro Antibiotic and Modulatory Activity of Mesosphaerum suaveolens (L.) Kuntze against Candida strains
Costa, A. R., Almeida‐Bezerra, J. W., da Cruz, R. P., de Freitas, M. A., da Silva, V. B., Neto, J. C., dos Santos, A. T. L., Morais‐Braga, M. F. B., da Silva, L. A., Rocha, M. I., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9020046 · Cited by 20 · see citing works
Prevalence of Vulvovaginal Candidiasis in Ahvaz, Southwest Iran: A Semi-Large Scale Study
Kiasat, N., Rezaei‐Matehkolaei, A., Mahmoudabadi, A. Z., Mohamadpour, K. H., Molavi, S., & Khoshayand, N. (2019) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.89815 · Cited by 19 · see citing works
Sodium glucose‐linked transport protein 2 inhibitors: An overview of genitourinary and perioperative implications
Chandrashekar, M., Philip, S., Nesbitt, A. L., Joshi, A., & Perera, M. (2021) · International Journal of Urology · doi:10.1111/iju.14624 · Cited by 19 · see citing works
Miconazole-loaded nanoparticles coated with hyaluronic acid to treat vulvovaginal candidiasis
Teixeira, A. D. R., Quaresma, A. D. V., Branquinho, R. T., Santos, S. L. E. N., Magalhães, J. T. D., Silva, F. H. R. D., Marques, M. B. D. F., Moura, S. A. L. D., Barboza, A. P. M., Araújo, M. G. D. F., et al. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106508 · Cited by 18 · see citing works
Candidiasis, Bacterial Vaginosis, Trichomoniasis and Other Vaginal Conditions Affecting the Vulva
Vieira‐Baptista, P., & Bornstein, J. (2019) · Springer eBooks · doi:10.1007/978-3-319-61621-6_24 · Cited by 18 · see citing works
The effect of curcumin-based and clotrimazole vaginal cream in the treatment of vulvovaginal candidiasis
Abbaspoor, Z., Abouali, N., Moghimipour, E., Mahmoudabadi, A. Z., & Namjouyan, F. (2019) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_584_19 · Cited by 16 · see citing works
Intravaginal boric acid: is it an alternative therapeutic option for vaginal trichomoniasis?
Thorley, N., & Ross, J. D. C. (2017) · Sexually Transmitted Infections · doi:10.1136/sextrans-2017-053343 · Cited by 15 · see citing works
Biofilm Formation and Aspartyl Proteinase Activity and Their Association with Azole Resistance Among Candida albicans Causing Vulvovaginal Candidiasis, Egypt
Gerges, M., Fahmy, Y., Hosny, T., Gandor, N., Mohammed, S., Mohamed, T., Abdelmoteleb, N. E. M., & Esmaeel, N. E. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s420580 · Cited by 8 · see citing works
Antifungal Activity and Type of Interaction of Melissa officinalis Essential Oil with Antimycotics against Biofilms of Multidrug-Resistant Candida Isolates from Vulvovaginal Mucosa
Ranđelović, M., Dimitrijević, M., Otašević, S., Stanojevic, L. P., Išljamović, M., Ignjatović, A., Arsić-Arsenijević, V. S., & Stojanović-Radić, Z. Z. (2023) · Journal of Fungi · doi:10.3390/jof9111080 · Cited by 14 · see citing works
Can Routine Histopathology Distinguish Between Vulvar Cutaneous Candidosis and Dermatophytosis?
Day, T., Foster, A. B., Phillips, S., Pagano, R., Dyall‐Smith, D. J., Scurry, J., & Garland, S. M. (2016) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000208 · Cited by 14 · see citing works
Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil
Brandão, L. D. S., Boniek, D., de Resende, M. A., da Mata, F. M. R., Azevedo, P. R. M., Fernandes, J. V., & Andrade, V. S. (2018) · Letters in Applied Microbiology · doi:10.1111/lam.13034 · Cited by 13 · see citing works
Design, synthesis and biological studies of some new imidazole-1,2,3-triazole hybrid derivatives
Dong, H., Wu, J.-G., & Huo, G. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.132516 · Cited by 12 · see citing works
Genotyping and Drug Resistance Profile of Clinical Isolates of Candida albicans from Vulvovaginal Candidiasis in the Eastern China
Hong, N., Yan, L., Chen, H., Chen, X., Tsui, C. K. M., Hu, D., Liao, W., Yan, L., Zhang, H., Zhao, R., et al. (2022) · Mycopathologia · doi:10.1007/s11046-022-00616-x · Cited by 11 · see citing works
The role of female intimate hygiene practices in the management of vulvovaginal candidiasis: A randomized, controlled open-label trial
Murina, F., Lubrano, C., Cappelli, E., Campo, M., & Taraborrelli, S. (2022) · Health Care For Women International · doi:10.1080/07399332.2022.2061972 · Cited by 11 · see citing works
Lyophilized tablets for focal delivery of fluconazole and itraconazole through vaginal mucosa, rational design and in vitro evaluation
Valle, M. J. D. J., Coutinho, P., Ribeiro, M. P., & Navarro, A. S. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.06.030 · Cited by 11 · see citing works
Treatment methods for vulvovaginal candidiasis in pregnancy
Bender, R. A., Çalışkan, Ş., Önal, B., Aslancan, R., & Çalışkan, E. (2021) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2021.101138 · Cited by 10 · see citing works
Diagnosis and treatment of vulvovaginal candidiasis: a practical approach
Cianci, A., Cicinelli, E., Colacurci, N., Leo, V. D., Perino, A., Pino, A., Bartolo, E., Randazzo, C. L., Esposito, G., Chiaffarino, F., et al. (2020) · Italian Journal of Gynaecology and Obstetrics · doi:10.36129/jog.32.04.05 · Cited by 9 · see citing works
Research progress of hydrogels in the prevention of pelvic inflammatory disease
Xiao, Y., Ma, T., Wu, H., Su, Q., Zhou, Y., Zhou, B., Yang, K., Pu, Z., Feng, W., Yong, X., et al. (2024) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.100 · Cited by 8 · see citing works
Evaluating the accuracy and diagnostic value of CFW and a new fluorescent reagents, fluorescent brightener 85, for the diagnosis of vulvovaginal candidiasis
Zhao, Y., Yu, Z., & Yue, X. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23891 · Cited by 8 · see citing works
Clinical Syndromes: Candida and Candidosis
Ruhnke, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-92300-0_4 · Cited by 7 · see citing works
Antimicrobial Activity of a Vaginal Gel Formulation: Considerations Related to Vaginal Infection and Dysbiosis
Seta, F. D., & Larsen, B. (2021) · Pathogens · doi:10.3390/pathogens10121576 · Cited by 7 · see citing works
Analysis of characteristics of vulvo-vaginal infections in 14- to 18-year-old girls in late puberty
Xu, L., Hu, Z., Fan, Y., & Tang, Y. (2020) · Journal of International Medical Research · doi:10.1177/0300060520946506 · Cited by 7 · see citing works
Interpretation of Nondiagnostic Vulvar Biopsies
Day, T., Knight, V., Dyall‐Smith, D. J., Dennerstein, G., Pagano, R., Tran, H., Tan, Y., Yap, D., Weigner, J., & Scurry, J. (2017) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000366 · Cited by 6 · see citing works
Vaginal Infection: Review Article
Al-Mugdadi, S. F. H., Al-Zwaini, Y. K. H., & Sayyid, M. M. A. (2022) · University of Thi-Qar Journal of Science · doi:10.32792/utq/utjsci.v9i1.867 · Cited by 6 · see citing works
Comparison of two long‐term gestagen regimens in the management of recurrent vulvovaginal candidiasis: A pilot study
Špaček, J., Kestřánek, J., Jílek, P., Leško, D., Plucnarová, S., & Buchta, V. (2017) · Mycoses · doi:10.1111/myc.12593 · Cited by 6 · see citing works
Clinicopathologic Overlap of Vulvar Psoriasis and Candidiasis
Day, T., Chapman-Burgess, E., & Scurry, J. (2024) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000801 · Cited by 5 · see citing works
Scope of translational medicine in developing boron-containing compounds for therapeutics
García-Ávila, A. K., Farfán‐García, E. D., Guevara‐Salazar, J. A., Trujillo-Ferrara, J. G., & Soriano-Ursua, M. A. (2017) · World Journal of Translational Medicine · doi:10.5528/wjtm.v6.i1.1 · Cited by 5 · see citing works
Antepartum vaginal Candida colonization and the risk for obstetrical tears
Hizkiyahu, R., Baumfeld, Y., Levy, D. P., Battat, T. L., Imterat, M., & Weintraub, A. Y. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1712701 · Cited by 5 · see citing works
Vaginitis por Candida glabrata: ¿la gran olvidada?
Arroyo-Fajardo, A., Juan-Delgado, M. F. S., & García‐Rodríguez, J. (2017) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2017.01.001 · Cited by 4 · see citing works
Sexually Transmitted Infections
Greenhouse, P. (2018) · Wiley eBooks · doi:10.1002/9781119211457.ch64 · Cited by 4 · see citing works
In vitro effects of glycyrrhetinic acid and hyaluronic acid on the growth of vulvovaginal Candida albicans and other yeasts
Stevan, M., Fusato, E., Armanini, D., Bertoloni, G., Seta, F. D., Leli, C., & Rassu, M. (2017) · Microbiologia medica · doi:10.4081/mm.2017.6974 · Cited by 4 · see citing works
Use of fluconazole in women of reproductive age with vulvovaginal candidiasis
Mezhevitinova, E. A., Abakarova, P. R., & Pogosyan, S. M. (2018) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2018-13-96-102 · Cited by 4 · see citing works
Síndrome de flujo vaginal (vaginitis / vaginosis): Actualización diagnóstica y terapéutica
Hoz, F. J. E. D. L. (2021) · Revista Peruana de Investigación Materno Perinatal · doi:10.33421/inmp.2021224 · Cited by 4 · see citing works
Sertaconazole in the treatment of vulvovaginal candidiasis
Efendieva, Z. (2019) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2019-13-94-98 · Cited by 3 · see citing works
Effect of norfloxacin therapy for acute, uncomplicated lower urinary tract infection on vaginal Candida prevalence
Rocha, R., Zanni, P., Mendonca, P., Gimenes, F., ALCZUK, S. D. S. D., Svidzinski, T. I. E., & Consolaro, M. E. L. (2015) · International Urogynecology Journal · doi:10.1007/s00192-015-2884-5 · Cited by 3 · see citing works
Prevalence of Candida Species Isolated from Vaginal Discharge of Women Undergoing in vitro Fertilization-Embryo Transfer in Vietnam
Ánh, Đ. N. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.14.002611 · Cited by 3 · see citing works
Recurrent vulvovaginal candidiasis associated with the use of a probiotic supplement
Neal, C. M., Gonzalez, A., Oshinowo, A. E., Fazle, T., & Kako, T. D. (2025) · IDCases · doi:10.1016/j.idcr.2025.e02285 · Cited by 2 · see citing works
Handlungsempfehlungen bei oraler Candidose unter Biologikatherapie bei Psoriasis – Ergebnisse eines Expertenmeetings
Meier, K., Beissert, S., Ghoreschi, K., Philipp, S., Schwarz, B., Tietz, H., & Asadullah, K. (2024) · Die Dermatologie · doi:10.1007/s00105-024-05410-y · Cited by 2 · see citing works
Vulvovaginal candidiasis: traditional therapy options
Рафиковна, Р. М., Bolshenko, B. N. V., & Tarasenko, E. N. (2020) · Russian Journal of Clinical Dermatology and Venereology · doi:10.17116/klinderma202019061855 · Cited by 2 · see citing works
Role of probiotics in prevention and treatment of Candida vaginitis and Bacterial vaginosis
Adesulu-Dahunsi, A. T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823733-5.00007-6 · Cited by 2 · see citing works
Roles of Candida albicans aspartic proteases in host-pathogen interactions
Gogól, M., Bocheńska, O., Zawrotniak, M., Karkowska-Kuleta, J., Zając, D., & Rapała-Kozik, M. (2017) · Springer eBooks · doi:10.1007/978-981-10-6141-7_15 · Cited by 4 · see citing works
Evaluation of Prevalence of Vaginal Candidiasis and Related Risk Factors: A Cross Sectional Study
Bala, M., Kumar, R. R., Magsi, S., Fatima, S., Nawaz, N., & Ashok, U. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22161604 · Cited by 1 · see citing works
Vulvo-vaginal candidiasis at the Zion Clinical Laboratory (Yaounde-Cameroon): risk factors, species distribution and antifungal susceptibility testing
Ngouana, T. K., Dougue, A. N., Ngouana, V., Tsayem, R. F., Mahamat, Y. H., Boyom, F. F., & Ranque, S. (2025) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2025.101590 · Cited by 1 · see citing works
"Exploring Novel Compounds from Soil Streptomyces: An Intervention for The Challenge of Drug Resistance and A Potential Avenue for New Drug Discovery"
Banji-Onisile, F. O. (2022) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2022.45.007169 · Cited by 1 · see citing works
The Presence of Lactobacillus spp. and its Effect on the Occurrence of Other Microorganisms in the Reproductive Tract of Polish Women
Kiecka, A., Rak, K., Białecka, J., Białecka, A., & Szczepanik, M. (2024) · Polish Journal of Microbiology · doi:10.33073/pjm-2024-024 · Cited by 1 · see citing works
Surface Modification of Zinc Undecylenate with Nanoparticle Fluconazole Using Low-Pressure RF Plasma-Assisted CVD: A New Generation Antifungal Compound
Bilici, N., & Bozduman, F. (2026) · AAPS PharmSciTech · doi:10.1208/s12249-025-03312-3 · Cited by 1 · see citing works
Alpha Defensins Genes and Vulvovaginal Candidiasis: A Study of Cases
Boatto, H. F., Francisco, E. C., Kleine, J. P. F. D. O., Silva, I. D., Girão, M. J. B. C., Machado, A. P., & Fischman, O. (2015) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2015.59071 · Cited by 1 · see citing works
Recent Advancements in Combinational Antifungal Therapy and Immunotherapy
Rathore, S. S., Ramakrishnan, J., & Raman, T. (2016) · Springer eBooks · doi:10.1007/978-81-322-2782-3_6 · Cited by 1 · see citing works
Features of fungal colonization of newborns from mothers with vulvovaginitis
Эйберман, А. С., Chernenkov, Y. V., & Геннадьевна, Б. Л. (2020) · CHILDREN INFECTIONS · doi:10.22627/2072-8107-2020-19-2-19-22 · Cited by 1 · see citing works
Accuracy in clinical examinations for the diagnosis of vulvovaginitis by CANDIDA SPP. and IN VITRO susceptibility to the main antifungals
Santos, A. S., Zara, A. L. D. S. A., Ataídes, F. S., da Silva, E. G., Freitas, V. A. Q., Costa, C. R., Silva, T. C., & Silva, M. D. R. R. (2020) · Revista de Patologia Tropical / Journal of Tropical Pathology · doi:10.5216/rpt.v49i3.64233 · Cited by 1 · see citing works
Prebiotics and Probiotics in Vulvovaginal Infections
Shah, P., Tandon, S., Purandare, A., Gandhi, A. B., Athota, K., Kumar, P. G., & Seth, S. (2022) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-2053 · Cited by 1 · see citing works
Comparison of Virtual Management of Vulvovaginal Candidiasis to Traditional In-Person Care
Murray, M. A., Penza, K. S., Furst, J. W., & Pecina, J. L. (2022) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2022.0218 · Cited by 1 · see citing works
In-vitro Antifungal Activities of Kombucha Tea Culture Supernatant Combined with Voriconazole against Vulvovaginal Candidiasis Clinical Isolates
Bassyouni, R. H., Ahmed, F. A., Ismaiel, A. A., Abdelmoneim, A., Badran, H., Zahry, M. A. E., Dwedar, R. A., & Wegdan, A. A. (2023) · Journal of Health Science and Medical Research · doi:10.31584/jhsmr.2023933 · Cited by 1 · see citing works
Infektionen
Büscher, U., Grubert, T. A., Kainer, F., Mylonas, I. G., & Wisser, J. (2016) · Elsevier eBooks · doi:10.1016/b978-3-437-23752-2.00018-3 · Cited by 1 · see citing works
KANDIDIASIS VULVOVAGINALIS PADA PASIEN SLE
Mawahdah, R., Ananingsih, P. D., Wahdini, S., Adawiyah, R., & Meutia, A. P. (2022) · Indonesian Journal for Health Sciences · doi:10.24269/ijhs.v6i2.4934 · Cited by 1 · see citing works
IS INTRAVAGINAL BORIC ACID AN ALTERNATIVE THERAPEUTIC OPTION FOR VAGINAL TRICHOMONIASIS?
Thorley, N. (2016) · doi:10.26226/morressier.5731a407d462b8028d88c843 · Cited by 1 · see citing works

Guideline vulvovaginal candidosis (2010) of the german society for gynecology and obstetrics, the working group for infections and infectimmunology in gynecology and obstetrics, the german society of dermatology, the board of german dermatologists and the german speaking mycological society
Mendling, W., & Brasch, J. (2012) · Mycoses · doi:10.1111/j.1439-0507.2012.02185.x · Cited by 110 · see citing works
Self-citation
Guideline: Vulvovaginal Candidosis (AWMF 015/072, Level S2k)
Farr, A., Effendy, I., Frey Tirri, B., Hof, H., Mayser, P., Petricevic, L., Ruhnke, M., Schaller, M., Schaefer, A. P. A., Sustr, V., et al. (2021) · Mycoses · doi:10.1111/myc.13248 · Cited by 184 · see citing works
Self-citation
Vulvovaginal candidiasis
LInhares, I., Haddad, J. M., Fukazawa, E. I., & Baracat, E. C. (2020) · doi:10.5680/lhuii000053
Vulvovaginal Candidosis
Bhesania, A. H., & Narayankhedkar, A. (2017) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2017.601.029 · Cited by 2 · see citing works
[Vulvovaginal mycoses].
Mendling, W. (1998) · PubMed
Self-citation

Authors: Mendling, W.
Affiliations: Deutsches Zentrum für Infektionen in Gynäkologie und Geburtshilfe Vogelsangstrasse 106 42109 Wuppertal Germany
Corresponding author: Mendling, Werner
ORCID: Mendling, Werner
Venue: Mycoses
Publisher: Wiley
Published: 2015-02-24
Volume: 58
Issue: S1
Pages: 1-15
ISSN: 0027-5557 (ISSN-L)
0933-7407
1439-0507
DOI: 10.1111/myc.12292
OpenAlex: W2164957395
Cited by: 117
References: 161
Citations by year: 2026: 1 · 2025: 6 · 2024: 7 · 2023: 6 · 2022: 12 · 2021: 19 · 2020: 17 · 2019: 8 · 2018: 11 · 2017: 11 · 2016: 12 · 2015: 7
FWCI: 10.64
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Mycoses (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
Keywords: candidal vaginitis, Candida albicans, Candida glabrata, non-albicans Candida, fungal culture, polyenes, imidazole, ciclopirox olamine, 5-fluorocytosine
MeSH terms: Antifungal Agents, Candida albicans, Candidiasis, Vulvovaginal, Female, Germany, Humans, Infant, Newborn, Microbial Sensitivity Tests, Microscopy, Phase-Contrast, Pregnancy, Pregnancy Complications, Infectious, Vaginal Discharge, Candida glabrata

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Guideline: Vulvovaginal Candidosis (AWMF 015/072), S2k (Excluding Chronic Mucocutaneous Candidosis)

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks